Top Industry Leaders in the Infectious Disease Diagnosis & Treatment Market
Latest Infectious Disease Treatment Companies Updates
Thermo Fisher Scientific expands its rapid molecular testing for respiratory infections: Their TaqPath Influenza A/B/RSV & SARS-CoV-2 Multiplex Assay received Emergency Use Authorization (EUA) from the FDA, offering simultaneous testing for common respiratory viruses.
Abbott partners with Gavi to distribute its Strep A test in low- and middle-income countries: This collaboration aims to improve access to early diagnosis and treatment for streptococcal infections.
Roche launches Elecsys® IL-6 test for early identification of sepsis: This new test helps distinguish sepsis from other inflammatory conditions, potentially leading to faster and more targeted treatment.
Merck & Co. announces positive Phase 3 results for its investigational oral antiviral for COVID-19: Molnupiravir, if approved, would offer another treatment option for patients with mild-to-moderate COVID-19.
Novartis receives FDA approval for Zolgensma, a gene therapy for spinal muscular atrophy (SMA): While not directly an infectious disease, Zolgensma represents a significant advancement in gene therapy treatments, with potential applications for other infectious diseases in the future.
List of Infectious Disease Treatment Key companies in the market:
- Hoffmann-La Roche Ltd (Switzerland)
- Pfizer Inc. (US)
- Janssen Global Services, LLC (US)
- Sanofi (France)
- GlaxoSmithKline PLC (UK)
- Novartis AG (Switzerland)
- Bristol-Myers Squibb Company (US)
- Bayer AG (Germany)
- Eli Lilly and Company (US)
- Astellas Pharma Inc. (Japan)
- Merck & Co., Inc. (US)